Aeglea Biotherapeutics, Inc. was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.99 to $5.22 in the past one-month time frame.

None of the estimates for this stock were revised in the last 30 days, while the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Aeglea Biotherapeutics carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Aeglea BioTherapeutics, Inc. Price

 

Aeglea BioTherapeutics, Inc. Price | Aeglea BioTherapeutics, Inc. Quote

A better-ranked stock in the same industry is Cellectis S.A. (CLLS Quick QuoteCLLS - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Best Place to Start Your Stock Search

Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>